Which of the following mutations is the most likely cause of sickle cell anemia?

Sickle cell disease affects millions of people worldwide. It is most common among people whose ancestors come from Africa; Mediterranean countries such as Greece, Turkey, and Italy; the Arabian Peninsula; India; and Spanish-speaking regions in South America, Central America, and parts of the Caribbean.

Sickle cell disease is the most common inherited blood disorder in the United States, affecting an estimated 100,000 Americans. The disease is estimated to occur in 1 in 500 African Americans and 1 in 1,000 to 1,400 Hispanic Americans.

Causes

Mutations in the HBB gene cause sickle cell disease. The HBB gene provides instructions for making one part of hemoglobin. Hemoglobin

consists of four protein subunits, typically, two subunits called alpha-globin and two subunits called beta-globin. The HBB gene provides instructions for making beta-globin. Various versions of beta-globin result from different mutations in the HBB gene. One particular HBB gene mutation produces an abnormal version of beta-globin known as hemoglobin S [HbS]. Other mutations in the HBB gene lead to additional abnormal versions of beta-globin such as hemoglobin C [HbC] and hemoglobin E [HbE]. HBB gene mutations can also result in an unusually low level of beta-globin; this abnormality is called beta thalassemia.

In people with sickle cell disease, at least one of the beta-globin subunits in hemoglobin is replaced with hemoglobin S. In sickle cell anemia [also called homozygous sickle cell disease], which is the most common form of sickle cell disease, hemoglobin S replaces both beta-globin subunits in hemoglobin. In other types of sickle cell disease, just one beta-globin subunit in hemoglobin is replaced with hemoglobin S. The other beta-globin subunit is replaced with a different abnormal variant, such as hemoglobin C. For example, people with sickle-hemoglobin C [HbSC] disease have hemoglobin molecules with hemoglobin S and hemoglobin C instead of beta-globin. If mutations that produce hemoglobin S and beta thalassemia occur together, individuals have hemoglobin S-beta thalassemia [HbSBetaThal] disease.

Abnormal versions of beta-globin can distort red blood cells into a sickle shape. The sickle-shaped red blood cells die prematurely, which can lead to anemia. Sometimes the inflexible, sickle-shaped cells get stuck in small blood vessels and can cause serious medical complications.

Learn more about the gene associated with Sickle cell disease

  • HBB

Inheritance

This condition is inherited in an autosomal recessive pattern

, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • HbS disease
  • Hemoglobin S disease
  • SCD
  • Sickle cell disorders
  • Sickling disorder due to hemoglobin S

Additional Information & Resources

Genetic Testing Information

  • Genetic Testing Registry: Hb SS disease

Genetic and Rare Diseases Information Center

  • Sickle cell anemia

Patient Support and Advocacy Resources

  • Disease InfoSearch
  • National Organization for Rare Disorders [NORD]

Research Studies from ClinicalTrials.gov

  • ClinicalTrials.gov

Catalog of Genes and Diseases from OMIM

  • SICKLE CELL ANEMIA

Scientific Articles on PubMed

  • PubMed

References

  • Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin [HbS] allele and sickle cell disease: a HuGE review. Am J Epidemiol. 2000 May 1;151[9]:839-45. doi: 10.1093/oxfordjournals.aje.a010288. Citation on PubMed
  • Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004 Feb 26;350[9]:886-95. doi: 10.1056/NEJMoa035477. Citation on PubMed
  • Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine [Baltimore]. 2005 Nov;84[6]:363-376. doi: 10.1097/01.md.0000189089.45003.52. Citation on PubMed
  • Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP. Sickle cell disease; a general overview. Neth J Med. 2004 Nov;62[10]:364-74. Citation on PubMed
  • Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol. 2001 Jan;112[1]:3-18. doi: 10.1046/j.1365-2141.2001.02557.x. No abstract available. Citation on PubMed
  • Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004 Oct 9-15;364[9442]:1343-60. doi: 10.1016/S0140-6736[04]17192-4. Citation on PubMed
  • Vichinsky E. New therapies in sickle cell disease. Lancet. 2002 Aug 24;360[9333]:629-31. doi: 10.1016/S0140-6736[02]09776-3. Citation on PubMed
  • Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004 Feb 26;350[9]:857-9. doi: 10.1056/NEJMp038250. No abstract available. Citation on PubMed

Enlarge image

Stay Connected

Sign up for the My MedlinePlus newsletter What's this?

GO

Related Health Topics

  • Genetic Disorders
  • Newborn Screening
  • Sickle Cell Disease

MEDICAL ENCYCLOPEDIA

  • Genetics
  • Sickle cell anemia
  • Sickle cell test

Related Medical Tests

  • Hemoglobin Electrophoresis
  • Hemoglobin Test

Understanding Genetics

  • What is the prognosis of a genetic condition?
  • How can gene variants affect health and development?
  • What does it mean if a disorder seems to run in my family?
  • What are the different ways a genetic condition can be inherited?
  • How are genetic conditions treated or managed?

Disclaimers

MedlinePlus links to health information from the National Institutes of Health and other federal government agencies. MedlinePlus also links to health information from non-government Web sites. See our disclaimer about external links and our quality guidelines.

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.

What mutations causes sickle

Sickle cell disease [SCD] is a genetic disorder caused by a mutation in both copies of a person's HBB gene. This gene encodes a component of hemoglobin, the oxygen-carrying protein in red blood cells. The mutation causes hemoglobin molecules to stick together, creating sickle-shaped red blood cells.

Is sickle

We now report an uncommon beta-thalassemia gene that contains a deletion of this nucleotide. Thus, one mutation [GAG leads to GTG] produces sickle-cell anemia, while the other [GAG leads to GG] eliminates beta-globin production.

What does the mutation for sickle

Normal hemoglobin [left] and hemoglobin in sickled red blood cells [right] look different; the mutation in the DNA slightly changes the shape of the hemoglobin molecule, allowing it to clump together.

Chủ Đề